Why Your Pre-Bed HGH Injection Is Built For The Wrong Body

Your liver converts growth hormone into IGF-1, but it does not do that job equally at all hours, and the timing of when you inject determines how much of that conversion you actually get.

To understand why, you need the full chain first. Your pituitary gland, a small structure at the base of your brain, releases growth hormone in pulses throughout the day. The largest of those pulses happens during slow-wave sleep, the deepest phase of your sleep cycle. That nocturnal pulse is so dominant that research from Van Cauter and Plat puts it at roughly 70 percent of your total daily growth hormone output. Once that hormone hits your bloodstream, it travels to your liver, and the liver converts it into something called IGF-1, which stands for insulin-like growth factor 1 and is the downstream signal actually responsible for most of the tissue-building effects people associate with growth hormone. The question is not whether your body can make IGF-1. The question is whether you are timing exogenous HGH in a way that helps or hurts that process.

Most people were taught to inject before bed, and that advice did not come from nowhere.

The logic made intuitive sense: growth hormone peaks at night naturally, so pin at night and ride the wave. The actual study behind that recommendation is Jorgensen et al. from 1990, and it compared evening versus morning injections in growth hormone deficient patients. The finding that got quoted for decades was that 24-hour IGF-1 levels came out essentially the same regardless of when those patients injected. No edge to evening. No edge to morning. A wash.

Here is what almost never gets mentioned about that study.

The subjects had no pituitary function. Their glands had stopped producing growth hormone on their own entirely. So when researchers were comparing evening and morning injections in those patients, they were working with a blank slate. There was no existing nocturnal pulse to interfere with. That context changes everything about how you apply those findings.

If you still have a functioning pituitary, you are not that patient.

Your body is already producing that large slow-wave sleep pulse every night regardless of what you inject. When you pin subcutaneous HGH at ten in the evening, the pharmacokinetics matter here. Research by Jorgensen on subcutaneous HGH absorption shows the hormone peaks in circulation roughly four hours after a subcutaneous injection. Pin at ten, peak at two in the morning. That two AM peak lands directly on top of the pulse your own pituitary is already generating.

Growth hormone is what is called counter-regulatory, which means it works against insulin. At the liver specifically, high growth hormone levels reduce insulin sensitivity, pushing glucose output up and blunting the liver's responsiveness to insulin signaling. This is the same mechanism behind what's known as the dawn phenomenon in type 1 diabetics, where nocturnal growth hormone spikes raise fasting blood glucose by decreasing hepatic insulin sensitivity. Perriello et al. demonstrated this clearly, showing that those overnight growth hormone spikes reduce both hepatic and extrahepatic insulin sensitivity, which is why you wake up with elevated fasting glucose when you are stacking an exogenous peak on top of your endogenous one.

Groggy, high fasting glucose, and you haven't even addressed the conversion problem yet.

IGF-1 production in the liver requires insulin to be present alongside growth hormone. Insulin acts as a permissive signal, essentially telling the liver that fuel is available and conditions are right to build. When growth hormone is rising at two in the morning and insulin is near zero because you've been fasted for hours, the liver is not in an optimal state to run that conversion. You get the growth hormone exposure without the co-signal that makes it productive.

The morning fasted injection flips this.

Pin when you wake up, fasted. Growth hormone begins rising in your bloodstream. Thirty to sixty minutes later you eat your first meal, which triggers insulin release. Now you have growth hormone climbing and insulin arriving in the same window, which is exactly the condition the liver needs to convert growth hormone into IGF-1 efficiently. You are hitting the conversion window instead of missing it. And because the injection happens in the morning, it has no interference with the slow-wave sleep pulse that will run on its own that night.

At doses around four IU or higher, a single morning injection produces a peak that fades before evening, so splitting the dose, morning and mid to late afternoon, keeps IGF-1 production running across a longer window without pushing any exogenous HGH into the overnight hours where it would collide with your endogenous pulse.

The practical upshot is straightforward: inject fasted in the morning, eat 30 to 60 minutes after, and do not pin within several hours of sleep if your pituitary is still functional.

The deeper issue here is that the pre-bed protocol got transplanted from a specific clinical population, pituitary-deficient patients with no endogenous pulse, into a completely different context where people have a functioning pituitary running its own nightly output. The data never supported evening injection as superior even in that original population. It just showed equivalence in people who had no natural pulse to protect. Apply that finding to someone with intact pituitary function and you are suppressing something your body gives you for free, missing the conversion window your liver actually needs, and driving metabolic disruption overnight for no additional return.

The protocol was never wrong for the patient it was designed for. It was just never designed for you.

---

References

1. Van Cauter E, Plat L. (1996). Physiology of growth hormone secretion during sleep. J Pediatr 128(5 Pt 2):S32-37. DOI: 10.1016/s0022-3476(96)70008-2
2. Jorgensen JO, Moller N, Moller J, Weeke J, Christiansen JS. (1985). Pharmacokinetics of biosynthetic authentic human growth hormone in normal men after subcutaneous or intramuscular injection. Acta Endocrinol (Copenh). PMID: 4034296
3. Jorgensen JO, Moller N, Lauritzen T, Alberti KG, Orskov H, Christiansen JS. (1990). Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 70(1):207-14. PMID: 2294131. DOI: 10.1210/jcem-70-1-207
4. Moller N, Jorgensen JO. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30(2):152-77. PMID: 19240267. DOI: 10.1210/er.2008-0027
5. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB. (1990). Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 33(1):52-9. PMID: 2406181. DOI: 10.1007/BF00586461

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness